Functional Brands shares rise 10.73% intraday after direct Nasdaq listing and strategic growth plans outlined.

Functional Brands Inc. surged 10.73% intraday after issuing a shareholder letter announcing its Nasdaq direct listing on November 5, 2025, and outlining a strategic growth plan centered on the Kirkman brand. The letter highlighted $6.5 million in consistent net revenue, a 1,300-basis-point gross margin improvement over three years, and initiatives such as a partnership with Market Performance Group, Google digital acceleration, and a direct-to-consumer platform (Tru2U). The company emphasized its FDA-registered manufacturing capabilities, stringent testing standards, and a competitive prenatal product (P2i by Kirkman) aligned with global health guidelines. The direct listing—chosen over a traditional IPO—signaled confidence in the business model and access to capital, while strategic moves to enhance margins and brand visibility reinforced growth potential. These developments, coupled with the CEO’s emphasis on long-term value creation, likely drove investor optimism and the sharp intraday rally.